# FDG and FDOPA PET Demonstration of Functional Brain Abnormalities

> **NCT04315584** · EARLY_PHASE1 · UNKNOWN · sponsor: **University of Virginia** · enrollment: 5 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **PROCEDURE:** Positron Emission Tomography
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Multiparametric Magnetic Resonance Imaging Scan
- **RADIATION:** Fludeoxyglucose F-18
- **RADIATION:** fluorine F 18 fluorodopa

## Key facts

- **NCT ID:** NCT04315584
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-15
- **Primary completion:** 2023-12-20
- **Final completion:** 2024-06-20
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2020-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04315584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04315584, "FDG and FDOPA PET Demonstration of Functional Brain Abnormalities". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04315584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*